FULGENT GENETICS, INC. Research and Development Expense
FULGENT GENETICS, INC. (FLGT) reported Research and Development Expense of $14.55 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-07-30
- FULGENT GENETICS, INC. research and development expense for the quarter ending 2026-06-30 was $14.55M, a 7.97% increase year-over-year.
- FULGENT GENETICS, INC. research and development expense for the quarter ending 2026-03-31 was $14.18M, a 14.37% increase year-over-year.
- FULGENT GENETICS, INC. research and development expense for the quarter ending 2025-12-31 was $14.17M, a 16.98% increase year-over-year.
- FULGENT GENETICS, INC. research and development expense for the quarter ending 2025-09-30 was $13.86M, a 17.63% increase year-over-year.
- FULGENT GENETICS, INC. research and development expense for fiscal 2025 was $53.91M, a 10.42% increase from fiscal 2024.
- FULGENT GENETICS, INC. research and development expense for fiscal 2024 was $48.82M, a 17.80% increase from fiscal 2023.
- FULGENT GENETICS, INC. research and development expense for fiscal 2023 was $41.44M, a 43.34% increase from fiscal 2022.
- FULGENT GENETICS, INC. research and development expense for fiscal 2022 was $28.91M, a 19.37% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $14.55M 10-Q · filed 2026-07-30 | $28.73M 10-Q · filed 2026-07-30 | $42.90M derived: sum of 3 quarters · filed 2026-07-30 | $56.76M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2026-03-31 | $14.18M 10-Q · filed 2026-05-01 | $28.35M derived: sum of 2 quarters · filed 2026-05-01 | $42.21M derived: sum of 3 quarters · filed 2026-05-01 | $55.69M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-12-31 | $14.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $28.03M derived: sum of 2 quarters · filed 2026-02-27 | $41.51M derived: sum of 3 quarters · filed 2026-07-30 | $53.91M 10-K · filed 2026-02-27 | |
| 2025-09-30 | $13.86M 10-Q · filed 2025-11-07 | $27.34M derived: sum of 2 quarters · filed 2026-07-30 | $39.73M 10-Q · filed 2025-11-07 | $51.85M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-06-30 | $13.48M 10-Q · filed 2026-07-30 | $25.88M 10-Q · filed 2026-07-30 | $37.99M derived: sum of 3 quarters · filed 2026-07-30 | $49.77M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-03-31 | $12.39M 10-Q · filed 2026-05-01 | $24.51M derived: sum of 2 quarters · filed 2026-05-01 | $36.29M derived: sum of 3 quarters · filed 2026-05-01 | $49.78M derived: sum of 4 quarters · filed 2026-05-01 | |
| 2024-12-31 | $12.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $23.90M derived: sum of 2 quarters · filed 2026-02-27 | $37.38M derived: sum of 3 quarters · filed 2026-02-27 | $48.82M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $11.78M 10-Q · filed 2025-11-07 | $25.27M derived: sum of 2 quarters · filed 2025-11-07 | $36.70M 10-Q · filed 2025-11-07 | $48.66M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-06-30 | $13.49M 10-Q · filed 2025-08-01 | $24.92M 10-Q · filed 2025-08-01 | $36.87M derived: sum of 3 quarters · filed 2026-02-27 | $46.89M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-03-31 | $11.43M 10-Q · filed 2025-05-02 | $23.39M derived: sum of 2 quarters · filed 2026-02-27 | $33.40M derived: sum of 3 quarters · filed 2026-02-27 | $43.09M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2023-12-31 | $11.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $21.97M derived: sum of 2 quarters · filed 2026-02-27 | $31.66M derived: sum of 3 quarters · filed 2026-02-27 | $41.44M 10-K · filed 2026-02-27 | |
| 2023-09-30 | $10.01M 10-Q · filed 2024-11-08 | $19.71M derived: sum of 2 quarters · filed 2024-11-08 | $29.49M 10-Q · filed 2024-11-08 | $38.00M derived: sum of 4 quarters · filed 2024-11-08 | |
| 2023-06-30 | $9.69M 10-Q · filed 2024-08-02 | $19.47M 10-Q · filed 2024-08-02 | $27.98M derived: sum of 3 quarters · filed 2024-08-02 | $35.49M derived: sum of 4 quarters · filed 2024-08-02 | |
| 2023-03-31 | $9.78M 10-Q · filed 2024-05-03 | $18.29M derived: sum of 2 quarters · filed 2024-05-03 | $25.80M derived: sum of 3 quarters · filed 2024-05-03 | $32.70M derived: sum of 4 quarters · filed 2024-05-03 | |
| 2022-12-31 | $8.51M 10-K · filed 2023-02-28 | $16.02M derived: sum of 2 quarters · filed 2023-11-03 | $22.92M derived: sum of 3 quarters · filed 2023-11-03 | $28.91M 10-K · filed 2025-02-28 | |
| 2022-09-30 | $7.51M 10-Q · filed 2023-11-03 | $14.41M derived: sum of 2 quarters · filed 2023-11-03 | $20.40M 10-Q · filed 2023-11-03 | $27.86M derived: sum of 4 quarters · filed 2023-11-03 | |
| 2022-06-30 | $6.91M 10-Q · filed 2023-08-04 | $12.89M 10-Q · filed 2023-08-04 | $20.36M derived: sum of 3 quarters · filed 2023-08-04 | $26.38M derived: sum of 4 quarters · filed 2023-08-04 | |
| 2022-03-31 | $5.99M 10-Q · filed 2023-05-05 | $13.45M derived: sum of 2 quarters · filed 2023-05-05 | $19.47M derived: sum of 3 quarters · filed 2023-05-05 | $24.79M derived: sum of 4 quarters · filed 2023-05-05 | |
| 2021-12-31 | $7.46M 10-K · filed 2023-02-28 | $13.48M derived: sum of 2 quarters · filed 2023-02-28 | $18.80M derived: sum of 3 quarters · filed 2023-02-28 | $24.22M 10-K · filed 2024-02-28 | |
| 2021-09-30 | $6.02M 10-K · filed 2023-02-28 | $11.33M derived: sum of 2 quarters · filed 2023-02-28 | $16.75M 10-Q · filed 2022-11-07 | $21.33M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-06-30 | $5.31M 10-K · filed 2023-02-28 | $10.73M 10-Q · filed 2022-08-04 | $15.31M derived: sum of 3 quarters · filed 2023-02-28 | $18.49M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-03-31 | $5.42M 10-K · filed 2023-02-28 | $10.00M derived: sum of 2 quarters · filed 2023-02-28 | $13.18M derived: sum of 3 quarters · filed 2023-02-28 | $15.02M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2020-12-31 | $4.58M 10-K · filed 2022-02-28 | $7.75M derived: sum of 2 quarters · filed 2022-02-28 | $9.60M derived: sum of 3 quarters · filed 2022-02-28 | $11.58M 10-K · filed 2023-02-28 | |
| 2020-09-30 | $3.18M 10-K · filed 2022-02-28 | $5.03M derived: sum of 2 quarters · filed 2022-02-28 | $7.00M 10-Q · filed 2021-11-09 | $8.80M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-06-30 | $1.85M 10-K · filed 2022-02-28 | $3.83M 10-Q · filed 2021-08-10 | $5.62M derived: sum of 3 quarters · filed 2022-02-28 | $7.37M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-03-31 | $1.98M 10-K · filed 2022-02-28 | $3.77M derived: sum of 2 quarters · filed 2022-02-28 | $5.52M derived: sum of 3 quarters · filed 2022-02-28 | $7.09M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2019-12-31 | $1.79M 10-K · filed 2021-03-08 | $3.54M derived: sum of 2 quarters · filed 2021-03-08 | $5.11M derived: sum of 3 quarters · filed 2021-03-08 | $6.54M 10-K · filed 2022-02-28 | |
| 2019-09-30 | $1.74M 10-K · filed 2021-03-08 | $3.32M derived: sum of 2 quarters · filed 2021-03-08 | $4.74M 10-Q · filed 2020-11-09 | $6.17M derived: sum of 4 quarters · filed 2021-03-08 | |
| 2019-06-30 | $1.57M 10-K · filed 2021-03-08 | $3.00M 10-Q · filed 2020-08-05 | $4.42M derived: sum of 3 quarters · filed 2021-03-08 | $5.86M derived: sum of 4 quarters · filed 2021-03-08 | |
| 2019-03-31 | $1.42M 10-K · filed 2021-03-08 | $2.85M derived: sum of 2 quarters · filed 2021-03-08 | $4.29M derived: sum of 3 quarters · filed 2021-03-08 | $5.50M derived: sum of 4 quarters · filed 2021-03-08 | |
| 2018-12-31 | $1.43M 10-K · filed 2020-03-13 | $2.86M derived: sum of 2 quarters · filed 2020-03-13 | $4.08M derived: sum of 3 quarters · filed 2020-03-13 | $5.53M 10-K · filed 2020-03-13 | |
| 2018-09-30 | $1.44M 10-K · filed 2020-03-13 | $2.65M derived: sum of 2 quarters · filed 2020-03-13 | $4.11M 10-Q · filed 2019-11-08 | $5.43M derived: sum of 4 quarters · filed 2020-03-13 | |
| 2018-06-30 | $1.21M 10-K · filed 2020-03-13 | $2.67M 10-Q · filed 2019-08-12 | $3.99M derived: sum of 3 quarters · filed 2020-03-13 | $5.12M derived: sum of 4 quarters · filed 2020-03-13 | |
| 2018-03-31 | $1.46M 10-K · filed 2020-03-13 | $2.78M derived: sum of 2 quarters · filed 2020-03-13 | $3.91M derived: sum of 3 quarters · filed 2020-03-13 | $4.83M derived: sum of 4 quarters · filed 2020-03-13 | |
| 2017-12-31 | $1.32M 10-K · filed 2019-03-22 | $2.45M derived: sum of 2 quarters · filed 2019-03-22 | $3.37M derived: sum of 3 quarters · filed 2019-03-22 | $4.22M 10-K · filed 2019-03-22 | |
| 2017-09-30 | $1.13M 10-K · filed 2019-03-22 | $2.05M derived: sum of 2 quarters · filed 2019-03-22 | $2.90M 10-Q · filed 2018-11-09 | $3.72M derived: sum of 4 quarters · filed 2019-03-22 | |
| 2017-06-30 | $920.00K 10-K · filed 2019-03-22 | $1.77M 10-Q · filed 2018-08-13 | $2.59M derived: sum of 3 quarters · filed 2019-03-22 | $4.11M derived: sum of 4 quarters · filed 2019-03-22 | |
| 2017-03-31 | $851.00K 10-K · filed 2019-03-22 | $1.67M derived: sum of 2 quarters · filed 2019-03-22 | $3.19M derived: sum of 3 quarters · filed 2019-03-22 | $3.85M derived: sum of 4 quarters · filed 2019-03-22 | |
| 2016-12-31 | $818.00K 10-K · filed 2018-03-20 | $2.34M derived: sum of 2 quarters · filed 2018-03-20 | $3.00M derived: sum of 3 quarters · filed 2018-03-20 | $3.56M 10-K · filed 2018-03-20 | |
| 2016-09-30 | $1.52M 10-K · filed 2018-03-20 | $2.18M derived: sum of 2 quarters · filed 2018-03-20 | $2.74M 10-Q · filed 2017-11-13 | $6.39M derived: sum of 4 quarters · filed 2018-03-20 | |
| 2016-06-30 | $656.00K 10-K · filed 2018-03-20 | $1.22M 10-Q · filed 2017-08-14 | $4.87M derived: sum of 3 quarters · filed 2018-03-20 | $5.18M derived: sum of 4 quarters · filed 2018-03-20 | |
| 2016-03-31 | $561.00K 10-K · filed 2018-03-20 | $4.21M derived: sum of 2 quarters · filed 2018-03-20 | $4.52M derived: sum of 3 quarters · filed 2018-03-20 | $4.78M derived: sum of 4 quarters · filed 2018-03-20 | |
| 2015-12-31 | $3.65M 10-K · filed 2017-03-17 | $3.96M derived: sum of 2 quarters · filed 2017-03-17 | $4.21M derived: sum of 3 quarters · filed 2017-03-17 | $4.43M 10-K · filed 2017-03-17 | |
| 2015-09-30 | $312.00K 10-K · filed 2017-03-17 | $311.00K 10-Q · filed 2016-11-14 | $564.00K derived: sum of 2 quarters · filed 2017-03-17 | $782.00K 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $252.00K 10-K · filed 2017-03-17 | $469.00K derived: sum of 2 quarters · filed 2017-03-17 | |||
| 2015-03-31 | $217.00K 10-K · filed 2017-03-17 | ||||
| 2014-12-31 | $521.00K 10-K · filed 2017-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |